Literature DB >> 6972921

Effect of the new immunosuppressive agent, cyclosporin-A, on natural killer cell and antibody-dependent cell-mediated cytotoxic activity.

A M Attallah, A Urritia-Shaw, T J Yeatman, T Folks.   

Abstract

Athymic nude mouse homozygotes (nu/nu) and the heterozygote nu/nu+ were injected intraperitoneally with 2 mg of cyclosporin-A (CS-A) twice, 72 and 1 h prior to analysis. We have found that in vivo administration of CS-A results in a significant suppression of natural killer (NK) cell and antibody-dependent cell-mediated cytotoxic (ADCC) activity which probably play an important role in tumor and graft rejection. T cells were also suppressed, in contrast, B cells were found to be immunocompetent as determined by cell proliferation and antibody-forming capacity in response to mitogens and antigens. The identity of cells mediating NK cell and ADCC activity and its relationship to T lymphocytes are also discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972921     DOI: 10.1159/000232789

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  The influence of cyclosporin A on the induction of experimental autoimmune thyroid disease in the PVG/c rat.

Authors:  R A Hassman; C Dieguez; D P Rennie; A P Weetman; R Hall; A M McGregor
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

2.  Effects of cyclosporin A on immunoglobulin production by EB virus stimulated lymphocytes.

Authors:  R S Pereira; A J Gear; C J Doré; A D Webster
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

3.  Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.

Authors:  S Yano; S Sone; Y Nishioka; M Naito; T Tsuruo; T Ogura
Journal:  Jpn J Cancer Res       Date:  1994-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.